原发性骨质疏松症诊治指南(2011年)

被引：1891

作者：

机构：

[1] 中华医学会骨质疏松和骨矿盐疾病分会

来源：

中华骨质疏松和骨矿盐疾病杂志 | 2011年 / 01期

关键词：

骨密度测定方法; 骨代谢; 疾病; 骨强度; 脆性骨折; 髓部; 骨质疏松症; 骨质疏松; 诊治指南;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

1002 ; 100201 ;

摘要：

2011年3月目录一、概述(一)定义和分类骨质疏松症(osteoporosis,OP)是一种以骨量低下,骨微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病(世界卫生组织,WHO)。2001年美国国立卫生研究院(NIH)提出骨质疏松症是以骨强度下降、骨折风险性增加为特征的骨骼系统疾病,骨强度反映骨骼的两个主要方面,即骨矿密度和骨质量。

引用

页码：2 / 17

页数：16

共 15 条

[1]

临床诊疗指南[M]. 人民卫生出版社 , 中华医学会编著, 2006

[2]

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials[J] . H A Bischoff-Ferrari,B Dawson-Hughes,H B Staehelin,J E Orav,A E Stuck,R Theiler,J B Wong,A Egli,D P Kiel,J Henschkowski.BMJ: British Medical Journal . 2009 (7725)

[3]

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years[J] . J.Y. Reginster,O. Bruyère,A. Sawicki,A. Roces-Varela,P. Fardellone,A. Roberts,J.P. Devogelaer.Bone . 2009 (6)

[4] European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J].

Kanis, J. A. ;

Burlet, N. ;

Cooper, C. ;

Delmas, P. D. ;

Reginster, J. -Y. ;

Borgstrom, F. ;

Rizzoli, R. .

OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) :399-428

[5] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard ;

Reid, Ian R. ;

Boonen, Steven ;

Cauley, Jane A. ;

Cosman, Felicia ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Mautalen, Carlos ;

Mesenbrink, Peter ;

Hu, Huilin ;

Caminis, John ;

Tong, Karen ;

Rosario-Jansen, Theresa ;

Krasnow, Joel ;

Hue, Trisha F. ;

Sellmeyer, Deborah ;

Eriksen, Erik Fink ;

Cummings, Steven R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822

[6]

Need for Additional Calcium to Reduce the Risk of Hip Fracture with Vitamin D Supplementation: Evidence from a Comparative Metaanalysis of Randomized Controlled Trials[J] . Steven Boonen,Paul Lips,Roger Bouillon,Heike A. Bischoff-Ferrari,Dirk Vanderschueren,Patrick Haentjens.The Journal of Clinical Endocrinology & Metabolism . 2007 (4)

[7]

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study[J] . J Y. Reginster,E Seeman,M C. De Vernejoul,S Adami,J Compston,C Phenekos,J P. Devogelaer,M Diaz Curiel,A Sawicki,S Goemaere,O H. Sorensen,D Felsenberg,P J. Meunier.The Journal of Clinical Endocrinology & Metabolism . 2005 (5)

[8]

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study[J] . P. D. Delmas,R. R. Recker,C. H. Chesnut,A. Skag,J. A. Stakkestad,R. Emkey,J. Gilbride,R. C. Schimmer,C. Christiansen.Osteoporosis International . 2004 (10)

[9] Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women [J].

Kung, AWC ;

Chao, HT ;

Huang, KE ;

Need, AG ;

Taechakraichana, N ;

Loh, FH ;

Gonzaga, F ;

Sriram, U ;

Ismail, NMN ;

Farooqi, A ;

Rachman, IA ;

Crans, GG ;

Wong, M ;

Thiebaud, D .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3130-3136

[10]

Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial[J] . Pierre D. Delmas,Kristine E. Ensrud,Jonathan D. Adachi,Kristine D. Harper,Somnath Sarkar,Carlo Gennari,Jean-Yves Reginster,Huibert A. P. Pols,Robert R. Recker,Steven T. Harris,Wentao Wu,Harry K. Genant,Dennis M. Black,Richard Eastell.The Journal of Clinical Endocrinology & Metabolism . 2002 (8)

← 1 2 →